Interview with Selwyn Kahanovitz, CEO, Litha Healthcare Group Limited
Mr Kahanovitz, Focus Reports came to South Africa in 2005 to produce a similar report on the South African pharmaceutical industry. Could you come back for us on the main…
Address: No 106, 16th Road, Midrand, 1686, Gauteng, South Africa
Tel: +27 11 516 1700
Web: http://www.lithahealthcare.co.za/
Litha Healthcare Group Limited is the result of the successful acquisition by Myriad Medical Holdings of Litha Healthcare Holdings (Proprietary) Limited in 2010.
Litha is a diversified healthcare company, with headquarters in Johannesburg, South Africa. Established in 1992 and with over 340 employees nationally, we are the only truly diversified Healthcare group listed on the Johannesburg Stock Exchange.
Litha Healthcare Group is divided into three Divisions;
Litha Biotech
Litha Medical
Litha Pharma
Within each Division there are 100% owned business units with the exception of The Biovac Institute which is a Public Private Partnership (PPP) between the SA Government and The Biovac Consortium.
Each Division is lead by a Divisional CEO. Litha Healthcare Group Limited provides healthcare solutions to hospitals, clinics, specialists pharmacies and general and allied practitioners either through distribution networks or directly.
The group’s diversified businesses include the following areas of healthcare:
Biotechnology : Vaccines
Medical devices : Consumables and Equipment
Pharmaceuticals : Generic, Ethical and Complimentary
Mr Kahanovitz, Focus Reports came to South Africa in 2005 to produce a similar report on the South African pharmaceutical industry. Could you come back for us on the main…
As COVID-19 threatens to derail more than a decade’s worth of hard-won gains in the fight against malaria, Dr Benjamin Pretorius, managing director at ERADA Technology Alliance, warns that diversions…
The South African affiliate of Indian pharma firm Cipla will begin manufacturing and distribution of remdesivir, a Covid-19 drug, in South Africa this month. The company’s priority is ensuring access…
Below is a roundup of latest news from South Africa’s life sciences and healthcare industries, including a call to overhaul patent laws to allow better access to COVID-19 drugs, innovation…
Kelly du Plessis is CEO & Founder of Rare Diseases South Africa, a registered NPO born out of necessity when her oldest child was diagnosed with Pompe disease at 11…
Trailing behind South Africa’s pharmaceutical market in both value and growth, the nation’s medical device industry has long enjoyed minimal barriers to entry and easy market access. But, with imminent…
The traditional model of healthcare has generally been limited to treatment in health facilities. But, when it comes to effectively treating more private and deeply personal health conditions, especially in…
Eclectic demographics, rapid patient recruitment, and a burgeoning population with a gradient of disease profiles—these seem to be the fundamentals truly driving growth in South Africa’s clinical trial industry. However,…
While South Africa faces a distinct set of challenges in effectively managing its healthcare sector, the ecosystem for innovation, particularly in the world of biotechnology remains fruitful. Bioentrepreneur Nick Duneas…
Hersol prides itself on producing high-quality products and is today one of the leading Pharmaceutical Contract Manufacturing Companies (CMOs) within the South African Market. The managing director discusses the development…
Albert Denoon (AB) and Jeff Hampton (JH) illustrate how the Crossroads and Campbell Institutes, two non-profit organizations funded by Baroque Medical, are well positioned to address South Africa’s current gaps…
The general manager of Bard SA, Charl De Klerk, illustrates the company’s growth ambitions within South Africa and Sub-Saharan Africa, while also depicting how Bard has adapted its therapeutic portfolio…
The head of KPMG’s life science division in Africa, Joubert Krugel, discusses the current state of South Africa’s healthcare system, the imminent trends taking place, and how the business community…
See our Cookie Privacy Policy Here
